MindMaze Therapeutics Holding SA (MMTZF)
Sector: Pharmaceutical Preparations
OTC:MMTZF
OTC:MMTZF
+6.58%$0.1798
Mkt Cap-
EV-
Float124.74M
O/S-
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
MCap-Float124.74MO/S-
Dilution
Pipeline3 lead-sponsored trials·1 active1 completed(5 more as collaborator)
Trials need funding. See this company's dilution risk and cash position.
Clinical Trials
Sponsor role
Status
- Not applicableTerminated
Study Evaluating the MindMotionPRO for Early Post-stroke Upper-limb Rehabilitation
MindMotionPRO, Self-Directed Prescribed Exercises
Stroke, Motor Disorders
NCT02688413Enrollment9StartAug 2016Primary CompletionAug 2017CompletionFeb 2018 - Not applicableCompleted
Immersive Virtual Reality for Stroke Motor Rehabilitation
MindMotion PRO
Chronic Stroke, Motor Disorders
NCT03094650Enrollment10StartFeb 2015Primary CompletionOct 2015CompletionNov 2015 - Not applicableRecruiting
Virtual-reality Exercises for Alleviating Attention Deficits in Patients With Acquired Brain Injury
Immersive virtual reality gamified cognitive activities, Double neuropsychological standard activities
Stroke, Attention Disorder
NCT05728840Enrollment135StartFeb 2023Primary CompletionJul 2026est.CompletionJul 2026est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Not applicable | Terminated | MindMotionPRO, Self-Directed Prescribed Exercises | NCT02688413 |
| Not applicable | Completed | MindMotion PRO | NCT03094650 |
| Not applicable | Recruiting | Immersive virtual reality gamified cognitive activities, Double neuropsychological standard activities | NCT05728840 |